Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Epigenetic markers and contrast-enhanced endoscopic ultrasonography in pancreatic cancer
2011-003248-36Phase 4Completed
- Sponsor
- Central Military Hospital
- Start
- Jul 2011
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 4 trial of sulfur hexafluoride in pancreatic cancer (PC), chronic pancreatitis (CP), sponsored by Central Military Hospital. Started Jul 2011; status: completed.
02
Drugs
sulfur hexafluoride
03
Conditions
pancreatic cancer (PC)chronic pancreatitis (CP)
Beyond the preview
Go deeper on 2011-003248-36.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2011-003248-36.